000150981 001__ 150981
000150981 005__ 20240428003815.0
000150981 0247_ $$2doi$$a10.1080/19336896.2016.1162644
000150981 0247_ $$2altmetric$$aaltmetric:8467363
000150981 0247_ $$2pmid$$apmid:27088811
000150981 037__ $$aDZNE-2020-01040
000150981 041__ $$aEnglish
000150981 082__ $$a570
000150981 1001_ $$0P:(DE-2719)2811280$$aLlorens Torres, Francesc Josep$$b0$$udzne
000150981 1112_ $$aPRION 2016$$cTokyo$$d2016-05-10 - 2016-05-13$$wJapan
000150981 245__ $$aIdentification of new molecular alterations in Fatal Familial Insomnia
000150981 260__ $$c2016
000150981 264_1 $$2Crossref$$3online$$bInforma UK Limited$$c2016-04-18
000150981 264_1 $$2Crossref$$3print$$bInforma UK Limited$$c2016-04-25
000150981 3367_ $$0PUB:(DE-HGF)1$$2PUB:(DE-HGF)$$aAbstract$$babstract$$mabstract$$s1713785216_6653
000150981 3367_ $$033$$2EndNote$$aConference Paper
000150981 3367_ $$2BibTeX$$aINPROCEEDINGS
000150981 3367_ $$2DRIVER$$aconferenceObject
000150981 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$mjournal
000150981 3367_ $$2DataCite$$aOutput Types/Conference Abstract
000150981 3367_ $$2ORCID$$aOTHER
000150981 520__ $$aFatal familial insomnia (FFI) is an autosomaldominant prion disease caused by a D178Nmutation in PRNP in combination with methio-nine at codon 129 in the mutated allele of thesame gene. The present study analyzes patho-logical and molecular features in 7 FFI casescarrying the mutation D178N and M homozy-gous at the codon 129 of PRNP. Severe neuro-nal loss and marked astrocytic gliosis wasobserved in every case in the mediodorsal andanterior nuclei of the thalamus whereas theentorhinal cortex (EC) was variably affected. Spongiform degeneration was only observed inthe EC. Synaptic and fine granular PrPScimmu-noreactivity was found in theECbut not in thal-amus. Microglia was barely increased in themediodorsal thalamus, but mRNA expressionof IL6, IL10RA, CSF3R and TLR7 was foundin the thalamus in FFI. PrPClevels were signifi-cantly decreased in the thalamus,ECand cere-bellum  in  FFI  compared  with  controls.However, increased expression of the non-gly-cosylated band of about 19 kDa was observedin the thalamus when using PrP antibodiesmapping to the central region of the PrP com-prising  thea-helix  domains  H1  and  H2.Decreased  PrP  mRNA  levels  were  alsoobserved in the thalamus andEC. Altered PrPsolubility was observed in FFI compared withcontrols; significantly reduced PrP levels in thecytoplasmic fraction and increased insolublelevels were found in FFI cases when comparedwith controls. Amyloid-like deposits were onlyseen in theEC. RT-QuIC assay which mimicsinvitrothe conversion of PrPc to misfolded andamyloid PrP revealed that all the FFI samplesof the entorhinal cortex were positive whereasthe thalamus was positive only in 3 cases; thecerebellum was positive in 2 cases. All controlswere negative. The expression of subunits ofmitochondrial respiratory complexes and com-ponents of the protein synthesis machineryfrom the nucleolus to the ribosome was ana-lyzed in the mediodorsal thalamus. NDUFB8(complex I subunit), SDHB (complex II sub-unit), UQCRC2 (complex III subunit), COX2(complex IV subunit) and ATP50 (complex Vsubunit) expression levels were reduced in FFI.Voltage-dependent anion channel and ATP5Hwere also reduced. In contrast, a markedincrease in superoxide dismutase 2 was foundin  reactive  astrocytes.  The  histone-bindingchaperones nucleolin and nucleoplasmin 3, andhistone H3 di-methylated K9 were markedlyreduced together with a decrease in the expres-sion of protein transcription elongation factoreEF1A in mediodorsal thalamus.
000150981 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x0
000150981 7001_ $$0P:(DE-2719)2811840$$aThüne, Katrin$$b1$$udzne
000150981 7001_ $$0P:(DE-2719)2811365$$aGotzmann, Nadine$$b2$$udzne
000150981 7001_ $$0P:(DE-2719)2810657$$aCramm, Maria$$b3$$udzne
000150981 77318 $$2Crossref$$3journal-article$$a10.1080/19336896.2016.1162644$$b : Informa UK Limited, 2016-04-18$$nsup1$$pS37-S127$$tPrion$$v10$$x1933-6896$$y2016
000150981 773__ $$0PERI:(DE-600)2267671-5$$a10.1080/19336896.2016.1162644$$nsup1$$pS37-S127$$tPrion$$v10$$x1933-6896$$y2016
000150981 8564_ $$uhttps://www.tandfonline.com/doi/pdf/10.1080/19336896.2016.1162644
000150981 8564_ $$uhttps://pub.dzne.de/record/150981/files/DZNE-2020-01040_Restricted.pdf
000150981 8564_ $$uhttps://pub.dzne.de/record/150981/files/DZNE-2020-01040_Restricted.pdf?subformat=pdfa$$xpdfa
000150981 909CO $$ooai:pub.dzne.de:150981$$pVDB
000150981 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811280$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000150981 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811840$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000150981 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811365$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000150981 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810657$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000150981 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x0
000150981 9141_ $$y2016
000150981 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPRION : 2018$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2020-01-17
000150981 915__ $$0LIC:(DE-HGF)CCBYNCNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial CC BY-NC (No Version)$$bDOAJ$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$f2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$f2020-01-17
000150981 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-01-17
000150981 9201_ $$0I:(DE-2719)1440011-1$$kAG Zerr$$lTranslational Studies and Biomarker$$x0
000150981 980__ $$aabstract
000150981 980__ $$aVDB
000150981 980__ $$ajournal
000150981 980__ $$aI:(DE-2719)1440011-1
000150981 980__ $$aUNRESTRICTED